Quantitative determination of nadolol in tablets by high-performance liquid chromatography and UV-derivative spectrophotometry

Analytical Letters

Volumn 41, Issue 3, 2008, Pages 424-436

  Tsubone, Camila ^a   García, Pedro López ^a   Gomes, Fabio Pereira ^a   Kedor Hackmann, Erika Rosa Maria ^a   Santoro, Maria Inês Rocha Miritello ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HPLC; Nadolol tablets; UV derivative spectrophotometry

Indexed keywords

EID: 39049089429     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710701689057     Document Type: Article

References (21)

1. Adegoke, O.A., Idowu, O.S., and Olaniyi, A.A. 2006. A new spectrophotometric method for the determination of nadolol. J. Ir. Chem. Soc., 3: 277-284.
2. Amin, A.S., Ragab, G.H., and Saleh, H. 2002. Colorimetric determination of β-blockers in pharmaceutical formulations. J. Pharm. Biomed. Anal., 30: 1347-1353.
3. Association of Official Analytical Chemists. 2003. Official Methods of Analysis, AOAC; AOAC Press: Gaithersburg.
4. Broch, S.C., Agustí, M.G., Peiró, M.E.C., and Romero, J.E. 2006. Micellar liquid chromatographic determination of five antianginals in pharmaceuticals. J. Pharm. Biomed. Anal., 41: 1235-1242.
5. Brunton, L.L., Lazo, J.S., and Parker, K.L. 2001. Goodman & Gilman's The Pharmacological Basis of Therapeutics; Mc Graw Hill: New York.
6. Delamoye, M., Duverneuil, C., Paraire, F., Mazancourt, P., and Alvarez, J.C. 2004. Simultaneous determination of thirteen β-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic Sci. Int., 141: 23-31.
7. Ghannam, S.M.A. 2006. A simple spectrophotometric method for the determination of β-blockers in dosage forms. J. Pharm. Biomed. Anal., 40: 151-156.
8. Gupta, R.N., Haynes, R.B., Logan, A.G., MacDonald, L.A., Pickersgill, R., and Achber, C. 1983. Liquid chromatographic determination of nadolol in plasma. Clin. Chem., 29: 1085-1087.
9. International Conference on Harmonization for Registration of Pharmaceuticals for Human Use (ICH). 2005. Validation of Analytical Procedures: Text and Methodology, Q2 (R1).
10. Liu, L.K. and Robinson, M.L. 1985. The determination of nadolol in biological samples using high-performance liquid chromatography. J. Pharm. Biomed. Anal., 3: 351-358.
11. Lukkari, P. and Sirén, H. 1995. Ion-pair chromatography and micellar electrokinetic capillary chromatography in analyzing beta-adrenergic blocking agents from human biological fluids. J. Chromatogr. A, 717: 211-217.
12. Martinéz, I.R., Coque, M.C.G.A., and Camañas, R.M.V. 1997. Liquid chromatographic procedure for the evaluation of β-blockers in pharmaceuticals using hybrid micellar mobile phases. J. Chromatogr. A, 765: 221-231.
13. Maurer, H.H., Tenberken, O., Kratzsch, C., Weber, A.A., and Peters, F.T. 2004. Screening for library-assisted identification and fully validated quantification of 22 β-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. J. Chromatogr. A, 1058: 169-181.
14. Moncrieff, J. 1985. Assay of nadolol in serum by reversed-phase high-performance liquid chromatography with fluorimetric detection. J. Chromatogr., 342: 206-211.
15. Noguchi, H., Yoshida, K., Murano, M., and Naruto, S. 1992. Determination of nadolol in serum by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr., 573: 336-338.
16. Ozden, S. and Gumus, F. 1988. Colorimetric determination of nadolol in tablets. Arch. Pharm., 391: 565-566.
17. Ranta, V.P., Toropainen, E., Talvitie, A., Auriola, S., and Urtti, A. 2002. Simultaneous determination of eight β-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J. Chromatogr. B, 772: 81-87.
18. Ribick, M., Ivashkiv, E., Jemal, M., and Cohen, A.I. 1986. Use of an inexpensive mass-selective detector for the high-sensitivity gas chromatographic determination of nadolol in plasma. J. Chromatogr., 381: 419-423.
19. Srinivas, N.R., Shyu, W.C., Shah, V.R., Campbell, D.A., and Barbhaiya, R.H. 1995. High-performance liquid chromatographic assay for the quantitation of nadolol in human plasma using fluorescence detection. Biomed. Chromatogr., 9: 75-79.
20. Thevis, M., Opfermann, G., and Schänzer, W. 2001. High-speed determination of beta-receptor blocking agents in human urine by chromatography/tandem mass spectrometry. Biomed. Chromatogr., 15: 393-402.
21. United States Pharmacopeia. 30 edn. 2007. The United States Pharmacopeial Convention, Inc: Rockville, USA.